Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Phase 3 Trial

Recent news which mentions Phase 3 Trial

< Previous 1 2 3 4 5 6 7 8 Next >
Scynexis Aces Ibrexafungerp Late-Stage Study To Prevent Vaginal Yeast Infections
Tickers SCYX
Tags Market News General Biotech
From Benzinga
Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia
Tickers ALKS
Tags General Schizophrenia Briefs
From Benzinga
Cingulate Outlines Plan For Pivotal Attention Deficit/Hyperactivity Disorder Studies
Tickers CING
Tags Market News News CING
From Benzinga
Why Are Vanda Pharma Shares Plunging Today?
Tickers VNDA
Tags Biotech Movers Benzinga
From Benzinga
Anavex Life Sciences Says Rett Syndrome Trial Meets Primary & Secondary Goals
Tickers AVXL
Tags Briefs Movers Biotech
From Benzinga
Valneva Kickstarts Phase 3 Trial Of Chikungunya Vaccine Candidate In Adolescents
Tickers VALN
Tags VALN General Small Cap
From Benzinga
Madrigal Pharma's Kidney Disease Candidate Improves Liver, Cardiovascular Health
Tickers MDGL
Tags Briefs Phase 3 Trial Benzinga
From Benzinga
Why Are Tyme Technologies Shares Staring At 52-Week Low
Tickers TYME
Tags Briefs Biotech Movers
From Benzinga
FDA Guides Annovis Bio For Two Phase 3 Buntanetap Trial In Parkinson's Disease
Tickers ANVS
Tags Health Care Trading Ideas News
From Benzinga
Achieve Life Sciences Initiates Pivotal Trial Of Cytisinicline For Smoking Cessation
Tickers ACHV
Tags General Market News News
From Benzinga
Sierra Oncology Shares Rally As Bone Marrow Cancer Candidate Hits Primary Goal
Tickers SRRA
Tags General Movers Biotech
From Benzinga
Lyra Therapeutics Kickstarts LYR-210 Pivotal Program in Surgically Naïve Chronic Rhinosinusitis Patients
Tickers LYRA
Tags General Market News Briefs
From Benzinga
On Positive Virology Data, SAB Biotherapeutics' COVID-19 Drug To Move To Phase 3 In NIH ACTIV-2 Trial
Tickers SABS
Tags General Phase 2 Trial Market News
From Benzinga
FDA Approves Gilead's Remdesivir For Non-Hospitalized COVID-19 Patients At High Risk For Disease Progression
Tickers GILD
Tags GILD Market News Health Care
From Benzinga
UCB's Bispecific Marks Phase 3 Win For Second Psoriatic Arthritis Study
Tickers UCBJF UCBJY
Tags General UCBJF UCBJY
From Benzinga
Alnylam' Reveals Detailed 18-Month Data From Vutrisiran Trial In Inherited Disease
Tickers ALNY
Tags General Market News ALNY
From Benzinga
KemPharm To Develop KP1077 As Lead SDX Candidate For Chronic Sleep Disorder
Tickers KMPH
Tags Market News KMPH News
From Benzinga
Seres Therapeutics' Oral Microbiome Candidate Shows Meaningful Improvements In Difficile Infection
Tickers MCRB
Tags Biotech Movers Phase 3 Trial
From Benzinga
EQRx's Sugemalimab Shows Significant Overall Survival Benefit In Lung Cancer Settings
Tickers EQRX
Tags Biotech Phase 3 Trial EQRX
From Benzinga
Second Dupixent Phase 3 Trial Confirms Significant Improvements In Inflammatory Skin Disease
Tickers REGN SNY
Tags General Market News SNY
From Benzinga
Merck's Keytruda Manages To Cross The Finish Line In Liver Cancer Confirmatory Trial
Tickers MRK
Tags FDA General Biotech
From Benzinga
RedHill Biopharma's Oral COVID-19 Treatment Improves Median Time To Viral RNA Clearance
Tickers RDHL
Tags General Phase 2 Trial Briefs
From Benzinga
Merck's Keytruda As Adjuvant Treatment Improves Disease-Free Survival In Lung Cancer Setting
Tickers MRK
Tags Phase 3 Trial Health Care Benzinga
From Benzinga
FDA Gives Green Signal To Reviva Pharma's Late-Stage Schizophrenia Trial
Tickers RVPH
Tags General FDA RVPH
From Benzinga
Oncternal, FDA In Pact For Pivotal Study Design For Zilovertam In Mantle Cell Lymphoma
Tickers ONCT
Tags Phase 3 Trial Benzinga Biotech
From Benzinga
Early Data Shows Novavax's COVID-19 Vaccine Triggers Immune Response To Omicron
Tickers NVAX
Tags Benzinga Phase 3 Trial Movers
From Benzinga
Gilead's Remdesivir Shows Consistent Efficacy In Patients With Comorbidities With Higher Risk for Severe COVID-19
Tickers GILD
Tags Benzinga COVID/19 Coronavirus Phase 3 Trial
From Benzinga
Allakos' Shares Nosedive After Lirentelimab Studies Fail To Achieve Statistical Significance On Symptomatic Endpoints
Tickers ALLK
Tags ALLK Short Ideas News
From Benzinga
Valneva Posts Positive Lot-to-Lot Consistency Data For Its Single-Dose Chikungunya Vaccine
Tickers VALN
Tags Market News VALN General
From Benzinga
DBV Technologies To Conduct New Pivotal Trial For Peanut Allergy Patch, Shares Plunge To 52-Week Low
Tickers DBVT
Tags why it's moving DBVT Market News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.